Mono Pharmacare Limited (NSE:MONOPHARMA)
India · Delayed Price · Currency is INR 10.25
+0.25 (2.50%)
Nov 11, 2026, 12:45 PM IST
Mono Pharmacare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 181 | 197 | 408 | 779 | - | - | |
Market Cap Growth | -48.75% | -51.73% | -47.62% | - | - | - |
Enterprise Value | 737 | 735 | 894 | 1,134 | - | - |
Last Close Price | 10.00 | 11.15 | 23.10 | 44.10 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 25.00 | 26.90 | 13.21 | 31.90 | - | - |
PS Ratio | 0.11 | 0.12 | 0.24 | 0.64 | - | - |
PB Ratio | 0.55 | 0.62 | 1.31 | 2.77 | - | - |
P/TBV Ratio | 0.55 | 0.62 | 1.31 | 2.78 | - | - |
P/FCF Ratio | 6.61 | 7.37 | - | - | - | - |
P/OCF Ratio | 6.60 | 7.36 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.44 | 0.44 | 0.53 | 0.93 | - | - |
EV/EBITDA Ratio | 16.21 | 16.27 | 11.46 | 17.72 | - | - |
EV/EBIT Ratio | 16.63 | 16.70 | 11.65 | 18.05 | - | - |
EV/FCF Ratio | 27.41 | 27.51 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.77 | 1.77 | 1.72 | 1.47 | 2.92 | 1.51 |
Debt / EBITDA Ratio | 12.51 | 12.51 | 6.86 | 6.48 | 17.37 | 4.63 |
Debt / FCF Ratio | 21.15 | 21.15 | - | - | - | 28.52 |
Net Debt / Equity Ratio | 1.74 | 1.74 | 1.69 | 1.46 | 2.89 | 1.45 |
Net Debt / EBITDA Ratio | 12.29 | 12.29 | 6.77 | 6.42 | 17.19 | 4.45 |
Net Debt / FCF Ratio | 20.78 | 20.78 | -11.67 | -4.59 | -0.98 | 27.43 |
Asset Turnover | 1.43 | 1.43 | 1.76 | 1.70 | 0.86 | 2.90 |
Inventory Turnover | 3.21 | 3.21 | 3.12 | 2.95 | 1.56 | 7.85 |
Quick Ratio | 1.20 | 1.20 | 0.81 | 0.89 | 0.66 | 0.67 |
Current Ratio | 1.92 | 1.92 | 2.07 | 2.24 | 1.82 | 1.64 |
Return on Equity (ROE) | 2.32% | 2.32% | 10.46% | 11.76% | 10.52% | 8.80% |
Return on Assets (ROA) | 2.37% | 2.37% | 5.02% | 5.47% | 3.65% | 6.27% |
Return on Invested Capital (ROIC) | 3.40% | 3.47% | 6.97% | 7.83% | 5.06% | 8.15% |
Return on Capital Employed (ROCE) | 7.50% | 7.50% | 13.40% | 13.90% | 7.70% | 22.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.00% | 3.72% | 7.57% | 3.14% | - | - |
FCF Yield | 15.12% | 13.56% | -11.10% | -11.48% | - | - |
Buyback Yield / Dilution | - | - | -15.09% | -171.01% | -15.18% | - |